Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Quantin

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Annals of the Rheumatic Diseases|February 19, 2020
Rheumatic disorders associated with immune checkpoint inhibitors: what about myositis? An analysis of the WHO's adverse drug reactions databaseThủy Nguyễn, Alexandre Thibault Jacques Maria, Chayma Ladhari, et al.
The European Respiratory Journal|October 18, 2014
High prevalence of undiagnosed COPD in a cohort of HIV-infected smokersAlain Makinson, Maurice Hayot, Sabrina Eymard-Duvernay, et al.
The European Respiratory Journal|May 24, 2020
First-line carboplatin plus pemetrexed with pemetrexed maintenance in HIV-positive patients with advanced non-squamous non-small cell lung cancer: the phase II IFCT-1001 CHIVA trialArmelle Lavole, Laurent Greillier, Julien Mazières, et al.
Respiratory Medicine and Research|October 29, 2025
Real-world management of unresectable stage III non-small-cell lung cancer: Impact of durvalumab consolidation therapy in French clinical practiceChristos Chouaid, Philippe Giraud, Marie Wislez, et al.
Advances in Therapy|February 13, 2026
Real-World Clinical Outcomes and Treatment Patterns in Advanced/Metastatic EGFR-Mutant NSCLC After Progression on First-Line Osimertinib for French PatientsNicolas Girard, Pauline Macouillard, Danalyn Byng, et al.
British Journal of Cancer|November 17, 2023
Circulating tumour cells and PD-L1-positive small extracellular vesicles: the liquid biopsy combination for prognostic information in patients with metastatic non-small cell lung cancerZahra Eslami-S, Luis Enrique Cortés-Hernández, Léa Sinoquet, et al.
Frontiers in Oncology|March 7, 2025
Real-world treatment and retreatment patterns and outcomes in patients with advanced or metastatic non-small cell lung cancer following nivolumab monotherapy in second line or later in France: an I-O Optimise analysisGrégoire Justeau, Christos Chouaid, Didier Debieuvre, et al.
Substance Use & Misuse|August 8, 2013
Feasibility and Efficacy of an Addiction Treatment Program in Patients With Upper Aerodigestive Tract CancerPascal Perney, Yohan Duny, Bertrand Nalpas, et al.
Plos One|January 8, 2019
Clinical efficacy and cost-effectiveness of endobronchial ultrasound-guided transbronchial needle aspiration for preoperative staging of non-small-cell lung cancer: Results of a French prospective multicenter trial (EVIEPEB)Christos Chouaid, Mathieu Salaün, Valérie Gounant, et al.
Journal of Geriatric Oncology|July 27, 2024
Real-world overview of therapeutic strategies and prognosis of older patients with advanced or metastatic non-small cell lung cancer from the ESME databaseMathilde Cabart, Loïc Mourey, David Pasquier, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Annals of the Rheumatic Diseases|February 19, 2020
Rheumatic disorders associated with immune checkpoint inhibitors: what about myositis? An analysis of the WHO's adverse drug reactions databaseThủy Nguyễn, Alexandre Thibault Jacques Maria, Chayma Ladhari, et al.
The European Respiratory Journal|October 18, 2014
High prevalence of undiagnosed COPD in a cohort of HIV-infected smokersAlain Makinson, Maurice Hayot, Sabrina Eymard-Duvernay, et al.
The European Respiratory Journal|May 24, 2020
First-line carboplatin plus pemetrexed with pemetrexed maintenance in HIV-positive patients with advanced non-squamous non-small cell lung cancer: the phase II IFCT-1001 CHIVA trialArmelle Lavole, Laurent Greillier, Julien Mazières, et al.
Respiratory Medicine and Research|October 29, 2025
Real-world management of unresectable stage III non-small-cell lung cancer: Impact of durvalumab consolidation therapy in French clinical practiceChristos Chouaid, Philippe Giraud, Marie Wislez, et al.
Advances in Therapy|February 13, 2026
Real-World Clinical Outcomes and Treatment Patterns in Advanced/Metastatic EGFR-Mutant NSCLC After Progression on First-Line Osimertinib for French PatientsNicolas Girard, Pauline Macouillard, Danalyn Byng, et al.
British Journal of Cancer|November 17, 2023
Circulating tumour cells and PD-L1-positive small extracellular vesicles: the liquid biopsy combination for prognostic information in patients with metastatic non-small cell lung cancerZahra Eslami-S, Luis Enrique Cortés-Hernández, Léa Sinoquet, et al.
Frontiers in Oncology|March 7, 2025
Real-world treatment and retreatment patterns and outcomes in patients with advanced or metastatic non-small cell lung cancer following nivolumab monotherapy in second line or later in France: an I-O Optimise analysisGrégoire Justeau, Christos Chouaid, Didier Debieuvre, et al.
Substance Use & Misuse|August 8, 2013
Feasibility and Efficacy of an Addiction Treatment Program in Patients With Upper Aerodigestive Tract CancerPascal Perney, Yohan Duny, Bertrand Nalpas, et al.
Plos One|January 8, 2019
Clinical efficacy and cost-effectiveness of endobronchial ultrasound-guided transbronchial needle aspiration for preoperative staging of non-small-cell lung cancer: Results of a French prospective multicenter trial (EVIEPEB)Christos Chouaid, Mathieu Salaün, Valérie Gounant, et al.
Journal of Geriatric Oncology|July 27, 2024
Real-world overview of therapeutic strategies and prognosis of older patients with advanced or metastatic non-small cell lung cancer from the ESME databaseMathilde Cabart, Loïc Mourey, David Pasquier, et al.
Pageof 9